Status:

UNKNOWN

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

Lead Sponsor:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions:

Predictive Cancer Model

Eligibility:

FEMALE

22-99 years

Brief Summary

Platinum-sensitive is an important basis for the treatment of recurrent epithelial ovarian cancer (EOC) without effective methods to predict.We aimed to develop and validate the EOC deep learning syst...

Eligibility Criteria

Inclusion

  • (1)Patients with epithelial ovarian cancer (2 )Patients received platinum-based chemotherapy (\>= 4 cycles) and debulking surgery

Exclusion

  • Patients with epithelial ovarian cancer received less than 4 cycles platinum-based chemotherapy or no debulking surgery

Key Trial Info

Start Date :

April 15 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2021

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT04511481

Start Date

April 15 2020

End Date

January 1 2021

Last Update

August 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sun Yat-Sen Memorial Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China, 510120

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer | DecenTrialz